Neal K. Shah is the Chief Executive Officer of CareYaya Health Technologies, one of LinkedIn’s 2024 Top 50 Startups in America. He runs a social enterprise and applied research lab utilizing AI ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Many digital health leaders are optimistic about the digital health sector in 2025, but still anticipate headwinds, a recent survey from Summit Health Advisors revealed. Summit Health Advisors is ...

Real-world data is invaluable to healthcare tech developers. This type of data reflects actual patient experiences, treatments and outcomes in diverse, real-world environments — rather than ...

The modern concept of “triage” dates to the Napoleonic Wars, when French battlefield surgeons developed a system for assessing the wounded and determining treatment priority to govern ...

Before the onset of the coronavirus pandemic in February 2020, there were 71 million people enrolled in Medicaid and Children’s Health Insurance Program (CHIP). Now, with the expiration of the ...

Pfizer’s research partnership with Sangamo Therapeutics produced a hemophilia A gene therapy that reached FDA discussions about a regulatory submission. That’s as far as the alliance will go.

While social media offers benefits, there are ample indicators that, coupled with smartphones, it poses a risk of harm to the mental health and well-being of children and adolescents. As a ...

Agitation caused by Alzheimer’s disease currently has one FDA-approved therapy, but that drug brings serious safety risks. An Axsome Therapeutics drug has mixed results from its latest slate of ...

In the patient payments space – just like healthcare information technology, in general – change happens at an accelerated pace. Across the healthcare industry, we are witnessing a rapid shift ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment ...